1. Home
  2. TRML vs CMRE Comparison

TRML vs CMRE Comparison

Compare TRML & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • CMRE
  • Stock Information
  • Founded
  • TRML 2021
  • CMRE 1974
  • Country
  • TRML United States
  • CMRE Monaco
  • Employees
  • TRML N/A
  • CMRE N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • CMRE Marine Transportation
  • Sector
  • TRML Health Care
  • CMRE Consumer Discretionary
  • Exchange
  • TRML Nasdaq
  • CMRE Nasdaq
  • Market Cap
  • TRML 1.2B
  • CMRE 1.3B
  • IPO Year
  • TRML N/A
  • CMRE 2010
  • Fundamental
  • Price
  • TRML $47.97
  • CMRE $11.61
  • Analyst Decision
  • TRML Hold
  • CMRE Hold
  • Analyst Count
  • TRML 12
  • CMRE 1
  • Target Price
  • TRML $47.04
  • CMRE $13.00
  • AVG Volume (30 Days)
  • TRML 657.3K
  • CMRE 489.4K
  • Earning Date
  • TRML 11-13-2025
  • CMRE 10-31-2025
  • Dividend Yield
  • TRML N/A
  • CMRE 3.96%
  • EPS Growth
  • TRML N/A
  • CMRE N/A
  • EPS
  • TRML N/A
  • CMRE 2.37
  • Revenue
  • TRML N/A
  • CMRE $2,085,912,000.00
  • Revenue This Year
  • TRML N/A
  • CMRE N/A
  • Revenue Next Year
  • TRML N/A
  • CMRE N/A
  • P/E Ratio
  • TRML N/A
  • CMRE $4.36
  • Revenue Growth
  • TRML N/A
  • CMRE 56.37
  • 52 Week Low
  • TRML $11.56
  • CMRE $6.02
  • 52 Week High
  • TRML $48.27
  • CMRE $13.16
  • Technical
  • Relative Strength Index (RSI)
  • TRML 90.29
  • CMRE 50.18
  • Support Level
  • TRML $47.88
  • CMRE $11.08
  • Resistance Level
  • TRML $48.00
  • CMRE $12.04
  • Average True Range (ATR)
  • TRML 0.05
  • CMRE 0.33
  • MACD
  • TRML -0.84
  • CMRE -0.00
  • Stochastic Oscillator
  • TRML 83.78
  • CMRE 63.49

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

Share on Social Networks: